Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
about
Serotonergic drugs and valvular heart diseaseSerotonin regulates C. elegans fat and feeding through independent molecular mechanismsPharmacological targeting of the serotonergic system for the treatment of obesityA potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychoticsInvolvement of 5-HT receptors in the regulation of food intake in Siberian hamsters.The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues.The utility of animal models to evaluate novel anti-obesity agents.Hypothalamic Ahi1 mediates feeding behavior through interaction with 5-HT2C receptor.Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studiesThe nucleus accumbens 5-HTR₄-CART pathway ties anorexia to hyperactivity.Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications.The effects of pharmacological modulation of the serotonin 2C receptor on goal-directed behavior in miceA review of late-stage CNS drug candidates for the treatment of obesity.Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel?Hypothalamic paraventricular 5-hydroxytryptamine inhibits the effects of ghrelin on eating and energy substrate utilization.Behavioral, pharmacological and neuroanatomical analysis of serotonin 2C receptor agonism on maternal behavior in rats.Regulation of body weight and carcass composition by sibutramine in rats.Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.Thermoregulatory, motor, behavioural, and nociceptive responses of rats to 3 long-acting neuroleptics.A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics
P2860
Q24646869-9194A678-B3A1-432F-B71F-69F121D41161Q24649629-7317766E-D19E-4891-AB17-B3478180BB06Q24658013-F7C61141-1413-4257-ADD3-68CB485CC82CQ33888821-9D99DADD-51E2-44B4-817B-8AA42AF713BFQ34415764-15F149CB-B73B-44F1-9EEF-C7857758FBA6Q34568502-04646FBB-0EF8-4A4C-BCAE-F7F64727DB12Q34655896-82E2C3EB-ED63-4A4A-800A-AD6788D87906Q35589958-B94FCD8D-5B54-4B6E-8E82-7478D091049EQ35694089-B1AF59D7-861E-4038-98E9-CD3675FDE75CQ36230583-07DB99F2-84EB-42D8-A927-057C57775B16Q36589680-78B5778B-502B-4BAB-91C3-B90DA185DD67Q36709588-8589A1B9-5538-4098-B135-8A028D46C54BQ36930837-A99EE76E-EEF0-4281-B68F-C7EB8CE8192AQ37992857-F57C779E-67CB-4748-AEF1-38B94E0DE9F7Q39768889-91C7A90A-41BC-4ED5-ACC9-EAC83EB48177Q42596581-4616BD93-4707-4497-8778-22414A641E7CQ42647430-BA73DCB0-674E-4F2F-909F-8856C0C9F842Q43911362-4C0471A2-F04F-417C-8D69-79EEE8FF633FQ44400212-2AF32AC0-DB1B-425D-95B9-634CC1D97265Q46622866-FE51F583-F938-4386-ADD7-B65E7AC581BDQ59206898-9AEDB2F9-8E92-409F-9454-7C1B9E166EEC
P2860
Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Comparative effects of continu ...... nd locomotor activity in rats.
@en
type
label
Comparative effects of continu ...... nd locomotor activity in rats.
@en
prefLabel
Comparative effects of continu ...... nd locomotor activity in rats.
@en
P2093
P2860
P356
P1476
Comparative effects of continu ...... and locomotor activity in rats
@en
P2093
G A Kennett
K R Benwell
M J Bickerdike
R H Porter
S P Vickers
P2860
P304
P356
10.1038/SJ.BJP.0703443
P407
P577
2000-07-01T00:00:00Z